400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Summary
The fund seeks to replicate the total return performance of the benchmark index before fees and expenses by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
As part of its strategy, the fund employs a passive or indexin More
Webiste
Directors
Jun 14, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Charles Park
Price
- $ 55.89 ( -3.87 )
-
Apr 10, 2025Last Close
- Net Assets
-
$5.4B
Feb 23, 2024
- 52-Week High/Low
- $65.1 - $54.3
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-9.97%
5 Year
-77.27%
Best
134.65%
2006
Worst
-79.27%
2020
Company Name |
Holding |
| ABBOTT LABORATORIES | 16.05 % |
| INTUITIVE SURGICAL, INC. | 14.01 % |
| STRYKER CORPORATION | 10.24 % |
| BOSTON SCIENTIFIC CORPORATION | 5.12 % |
| EDWARDS LIFESCIENCES CORPORATION | 4.75 % |
| BECTON, DICKINSON AND COMPANY | 4.51 % |
| DEXCOM, INC. | 4.37 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 4.37 % |
| MEDTRONIC PUBLIC LIMITED COMPANY | 4.32 % |
| IDEXX LABORATORIES, INC. | 4.28 % |
| More | 4.28 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IHI | 0% | 2.9% | 2.7% | -20.1% | 20.7% | -79.3% | 31.6% | 15.5% | 30.8% | 9.3% | |
| S&P 500 | -4.7% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 8.6% | 2.7% | -7.3% | 0.8% | -14.3% | 15.9% | 6.6% | 13.8% | 0% | ||||
| q2 | 0% | -0.2% | 4.6% | -17.3% | 9.6% | 17.5% | 4.2% | 11.2% | 10.1% | 10.8% | ||||
| q3 | 0% | 0% | -14.1% | -6.5% | 4.1% | -81.2% | 1.9% | 13.1% | 0.4% | 7.4% | ||||
| q4 | 0% | 0% | 11.8% | 11.4% | 5% | 9.4% | 6.3% | -12.1% | 3.2% | -8.2% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 3.5% | 1.8% | 3.1% | -6.1% | 1.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |